View in EDS

CfDNA as a surrogate marker for COVID-19 severity in patients with influenza-like symptoms with and without SARS-CoV-2 infection in general practice: a prospective cohort study.

Saved in:

Bibliographic Details
Title:	CfDNA as a surrogate marker for COVID-19 severity in patients with influenza-like symptoms with and without SARS-CoV-2 infection in general practice: a prospective cohort study.
Authors:	Dehnen D; Institute of General Practice, Medical Faculty, University of Duisburg-Essen, Essen, Germany. dorothea.dehnen@uk-essen.de., Botzenhardt S; West German Cancer Center, University Hospital Essen, Essen, Germany., Giagkou E; Institute of General Practice, Medical Faculty, University of Duisburg-Essen, Essen, Germany., Enders K; Department of Sports Medicine, Rehabilitation and Disease Prevention, Johannes Gutenberg University of Mainz, Mainz, Germany., Hoeter K; Department of Anaesthesiology, University Medical Centre of the Johannes Gutenberg- University, Mainz, Germany., Simon P; Department of Sports Medicine, Rehabilitation and Disease Prevention, Johannes Gutenberg University of Mainz, Mainz, Germany., Neuberger EWI; Department of Sports Medicine, Rehabilitation and Disease Prevention, Johannes Gutenberg University of Mainz, Mainz, Germany.
Source:	Virology journal [Virol J] 2025 Dec 01; Vol. 22 (1), pp. 390. Date of Electronic Publication: 2025 Dec 01.
Publication Type:	Journal Article
Journal Info:	Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X (Electronic) Linking ISSN: 1743422X NLM ISO Abbreviation: Virol J Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1743-422X
DOI:	10.1186/s12985-025-03016-x